Mechanical Determinants of Upper Limbs Oscillation During Gait
Trial
N/A
Completed
Nov. 17, 2025
Influence of Autonomy on Motor Learning in People With Parkinson's Disease
Trial
N/A
Recruiting
Nov. 17, 2025
Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study
Trial
N/A
Completed
Nov. 17, 2025
A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease
Trial
Phase 1
Completed
Nov. 17, 2025
Clinical Research on Stem Cell Therapy for Parkinson's Disease
Trial
Phase 1
Not yet recruiting
Nov. 17, 2025
Superior Colliculus Activity in Parkinson Disease: a Potential Marker?
Trial
N/A
Completed
Nov. 17, 2025
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor
Trial
Phase 3
Completed
Nov. 16, 2025
Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation
Trial
N/A
Active, not recruiting
Nov. 16, 2025
Effectiveness of Video-Based Upper Extremity Exercise Program in Parkinson's Disease
Trial
N/A
Completed
Nov. 16, 2025
DB RCT for Specialized Phototherapy in Parkinson's Disease.
Trial
N/A
Active, not recruiting
Nov. 12, 2025
Music Therapy to Prevent Hospital-acquired Delirium in Parkinson's Disease and Dementia With Lewy Bodies
Trial
N/A
Completed
Nov. 12, 2025
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Trial
Phase 1
Recruiting
Nov. 11, 2025
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
Trial
N/A
Recruiting
Nov. 9, 2025
Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease
Trial
N/A
Active, not recruiting
Nov. 4, 2025
Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming
Trial
N/A
Completed
Nov. 3, 2025
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease
Trial
Phase 1
Completed
Nov. 3, 2025
Kinematic and Neural Dynamics of Postural Instability in Parkinson's Disease
Trial
N/A
Recruiting
Nov. 2, 2025
A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease
Trial
Phase 1
Terminated
Oct. 28, 2025